Synthesis, radiolabeling and biodistribution studies of [99mTc(CO)3(MN-TZ-BPA)]+ in tumor-bearing mice

This study reports the synthesis, radiolabeling and preliminary biodistribution results of [^99mTc(CO)₃(MN-TZ-BPA)]⁺ in tumor-bearing mice. The novel nitroimidazole derivative was successfully synthesized by conjugation of bis(pyridin-2-ylmethyl)amine (BPA) to 2-methyl-5-niroimidazole via “click” reaction. The ligand could be labeled by [^99mTc(CO)₃]⁺ core in high yield to get [^99mTc(CO)₃(MN-TZ-BPA)]⁺, which was very hydrophilic and was stable at room temperature. Biodistribution studies in tumor-bearing mice showed that [^99mTc(CO)₃(MN-TZ-BPA)]⁺ accumulated in the tumor with certain initial uptake while poor retention. The rapid clearance from normal organs with favorable tumor/muscle ratios warrants further research to improve tumor targeting efficacy and pharmacokinetic profile of radiolabeled nitroimidazoles by structural modification.     

Labeling of famotidine with 99mTc and biodistribution studies on rats

Famotidine, a gastrointestinal drug was labeled with ^99mTc and its radiopharmaceutical potential was observed on male Albino Wistar rats. Labeling yield was over 95%. Average specific activity and n-octanol/water partition coefficient (lipophilicity) were approximately 74 MBq/mg-0.66 GBq/mg and 3.4, respectively. Biodistribution studies were performed on Albino Wistar rats. The activity per gram tissue was calculated and time-activity curves were generated. The majority of the activity was observed in stomach, small intestines and kidneys. Liver and kidneys showed lower uptake compared to other H₂-receptor rich tissues. Results show that ^99mTc-famotidine is H₂receptor specific. This revised version was published online in July 2006 with corrections to the Cover Date.     

Labeling of scorpion venom with 99mTc and its biodistribution

Labeling of scorpion venom (SV) was successfully achieved with ^99mTc using direct chelating method. Venom was labeled with ^99mTc using stannous chloride as reducing agent. Preliminary studies were done to establish the optimum conditions for obtaining the highest yield of the labeled venom. The labeling technique is effective, as a maximum labeling yield (97 %) was obtained after 30-min reaction time by using 80 μg SV in phosphate buffer of pH 7 and 25 μg Sncl₂·2H₂O at room temperature. Venom was injected into normal mice to determine the excretion pathway. Biodistribution studies in normal mice with SV shows rapid clearance of the venom from blood and tissue except for kidneys. The improvement of the immunotherapeutic treatment of envenomation requires a better knowledge of the biological actions of the SV since tissue distribution studies are very important for clinical purpose.     

Altered [99mTc]Tc-MDP biodistribution from neutron activation sourced 99Mo

Journal of Radioanalytical and Nuclear Chemistry - Given potential worldwide shortages of fission sourced 99Mo/99mTc medical isotopes there is increasing interest in alternate production...     

Labelling and quality control of gentamycin with99mTc and biodistribution

Gentamycin sulfate (antibiotic) was labelled with^99mTc with high radioactive yield. Technetium species were studied using different types of sephadex on columns. Stannous chloride was used as reducing agent for heptavalent^99mTc obtained directly from generator to lower oxidation state prior to labelling. Optimal pH was found to form the most stable complex. A lyophilized kit was prepared and it was stable for more than three months. Mice, rats and rabbits have been used as exprimental animals. Accumulation of more than 20% of the labelled formula in kidneys 30 minutes post injection in rats has been found. Gamma camera images in rabbit were clear enough for kidney delineation thirty minutes after injection.     

Synthesis and biodistribution of a novel 99mTc nitrido radiopharmaceutical with proline dithiocarbamate as a potential tumor imaging agent

In the present study, proline dithiocarbamate (PRODTC) ligand was radiolabeled with the [^99mTc≡N]²⁺ core successfully to obtain the ^99mTcN-PRODTC complex with high radiochemical purity. No decomposition of the complex at room temperature was observed over a period of 6 h. Its partition coefficient indicated that it was a hydrophilic complex. The electrophoresis results showed that the complex was negative. The biodistribution of ^99mTcN-PRODTC in mice bearing S 180 tumor showed that the complex accumulated in the tumor with a certain uptake. The tumor/blood and tumor/muscle ratios reached 2.19 and 4.54 at 2 h post-injection, suggesting it would be a promising candidate for tumor imaging.     

Separation of99mTc from parent99Mo by solid-phase column extraction as a simple option for a new99mTc generator concept

Evidence is obtained to show that the liquidliquid extraction separation of^99mTc from⁹⁹Mo with methyl ethyl ketone, methyl propyl ketone and methyl isobutyl ketone can be transformed into a solid-phase column extraction procedure. The aqueous alkaline⁹⁹molybdate solution is immobilized on a column of a granular large-pore diatomaceous earch support, which is the neluted with the abovementioned extractants. Rapid and clean separation of^99mTc can be with all three solvents. The^99mTc can be back-extracted from the organic phase on a column filled with distilled water /or saline/ loaded granular diatomaceous earth /Extrelut^®/. The possibility of using the abovementioned procedure as a basis for a new^99mTc/⁹⁹Mo generator concept is envisaged.     

Influence of different 99mTc cores on the physicochemical and biodistribution behaviours of 99mTc-labelled complexes of pamidronate dithiocarbamate

Journal of Radioanalytical and Nuclear Chemistry - This study sought to evaluate the impact of 99mTcO and 99mTc≡N cores on the physicochemical and biodistribution properties of 99mTc-labelled...     

Hydrated titanium dioxide as an adsorbent for99Mo−99mTc generator

The adsorption behaviour of⁹⁹Mo in the form of molybdate and of^99mTc in the form of pertechnetate on hydrated titanium dioxide was investigated at different molarities of hydrochloric acid. The adsorption capacity of molybdate on hydrated TiO₂ is higher than on Al₂O₃. A^99mTc-generator is suggested. This generator is based on the adsorption of (⁹⁹Mo) molybdate on hydrated TiO₂, at acidities of 0.05–0.1M. HCl.^99mTc is eluted with 0.9% NaCl. Radionuclidic, radiochemical and chemical purities of the eluates were checked. This generator seems to have a great potential as compared to the traditional alumina generators.     

99mTc generator with hydrated MnO2 as adsorbent of 99Mo

An ^99mTc generator with MnO₂ as adsorbent of ⁹⁹Mo was investigated. Through batch experiments the retention of ⁹⁹Mo onto MnO₂was studied as a function of the shaking time and the pH value of the ⁹⁹Mo solution. It was found that ⁹⁹Mo showed a retention of 100% onto MnO₂ at the pH range from 3 to 11, and the equilibrium distribution was reached in less than 10 minutes. In column experiments the retention of ⁹⁹Mo onto MnO₂ was also high: 99.72%. In this case, the pH of the utilized ⁹⁹Mo solution was 5. The ^99mTc could be eluted from the MnO₂-⁹⁹Mo column by using either distilled water with a pH of 5 or an aqueous solution of 0.9% NaCl. With the saline solution, the ^99mTc elution yields were higher than 80%, and only one aliquot of 5 ml was needed to get these yields. The best results were obtained when the column was packed with 1 g of MnO₂. The water and the saline solution were passed through the column at a rate of 1.25 ml/min.     

Synthesis and biodistribution of two novel 99mTc “3+1”mixed ligand complexes as potential brain perfusion agents

The research in the last decade has been mainly aimed at the development of technetium-99m radiopharmaceuticals, among which are the “3+1”mixed ligand complexes. Two novel [^99mTc]“3+1”mixed ligand complexes each carrying the tridentate ligand, the N-(o-Methylthiophenyl)ethylenediamine or the N-(o-Methylthiophenyl)-b-mercaptoacetamide in combination with monothiolate coligand were produced using stannous chloride as reductant and glucoheptonate as transfer ligand. The identification of [^99mTc]-6 and [^99mTc]-7 was established by thin layer chromatography. The radiochemical purity of two complexes was over 90%. Biodistribution data in mice showed that both [^99mTc]-6 and [^99mTc]-7 can penetrate the intact blood-brain barrier and exhibited retention in mice brain. The brain uptakes (%ID/g) were 1.76, 1.17, 0.90 and 0.68, 0.38 ,0.37 at 2, 30, and 60 minutes i.v. postinjection for [^99mTc]-6 and [^99mTc]-7, respectively. Examples in this report comfirm us that it is promising to develop ^99mTc complexes as potential brain perfusion agents based on modifying either the tridentate or the monodentate ligands. This revised version was published online in August 2006 with corrections to the Cover Date.     

Radiolabeling of DNA nanostructure with 99mTc using DTPA as a chelate

In the field of nanotechnology, DNA-based nanoscale materials have facilitated the construction of DNA polyhedrons with different shapes and sizes by using predictable base pairing and highly tunable conformation. In this study DNA bipyramid nanostructures with one arm chain (T20-DBNs) were successfully prepared in a single annealing procedure. ^99mTc-A20 ssDNA was obtained by radiolabeled DTPA-A20 with ^99mTc, and then ^99mTc-DTPA-DBNs were obtained by hybridizing T20-DBNs with ^99mTc-A20 ssDNA. We focused on studying a method of ^99mTc radiolabeling DNA nanostructures with DTPA as a chelate, and hoped to develop a new SPECT molecular imaging probe based on DNA nanostructures.

     

99mTc放射性药物中的配位化学

在99mTc间接标记放射性药物中双功能螯合剂起到重要的连接作用,其在很大程度上决定了放射性药物的理化性质。99mTc标记放射性药物中常用的双功能螯合剂大都含有N、S、P等杂原子,本文以与锝核配位杂原子的不同对双功能螯合剂进行分类,分别对NxS(4-x)型配体、“3＋1”混合配体、含膦配体以及以[99mTc(CO)3]+为配位中心的99mTc放射性药物逐一进行介绍。     

99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers

Nuclear medicine relies on two main imaging modalities: single photon emission computed tomography (SPECT) and positron emission tomography (PET). Radiopharmaceuticals (or radiotracers) are the blood stream of nuclear medicine for the diagnosis or therapy of diseases. Diagnostic radiotracers that are small molecules labelled with a gamma-emitter for SPECT or positron-emitter for PET provide a non-invasive method to assess the disease or disease states and monitor the therapeutic efficacy of a specific treatment regime. Over the past four decades, radiopharmaceutical research has been practising one-pot synthesis at the tracer level (10(-7)-10(-6) M). Many (99m)Tc radiotracers currently used in nuclear medicine are routinely prepared by following the basic principles of one-pot synthesis. Unlike traditional organic one-pot synthesis, which often involves the formation of multiple C-C and C-heteroatom bonds in a single step, the (99m)Tc-centered one-pot synthesis requires the formation of multiple coordination bonds between Tc and various donor atoms, such as N, O, S and P. This review will illustrate how the (99m)Tc-centered one-pot synthesis is utilized for routine preparations of different (99m)Tc radiotracers.     

Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals

In a search of coordination molecules suitable to the fac-{(99m)Tc(CO)3}(+) core as a synthon for (99m)Tc-radiopharmaceuticals, nonradioactive rhenium complexes of two macrocyclic triamine compounds with different chelate ring structures, 1,4,7-triazacyclononane (9N3) and 1,5,9-triazacyclododecane (12N3), were synthesized and characterized. (99m)Tc-labeled 9N3 and 12N3 compounds were also prepared using [(99m)Tc(OH 2)3(CO)3](+) and were characterized by both in vitro and in vivo studies. 9N3 produced a single rhenium complex, whereas 12N3 generated two major complexes. The crystallographic data and infrared absorption wavenumber assigned to the C-O stretch suggested that the coordination geometry of 9N3 would be more suitable to fac-{Re(CO)3}(+) than that of 12N3. In contrast, both 9N3 and 12N3 provided a single (99m)Tc-labeled compound. However (99m)Tc-labeled 9N3 exhibited higher stability than (99m)Tc-labeled 12N3 in rat plasma and in the presence of histidine at an elevated temperature. In biodistribution studies, both (99m)Tc-labeled compounds did not show any specific accumulation of radioactivity in any organs except for the excretory organs such as the liver and kidney. These findings showed that 9N3 would constitute a macrocyclic chelating molecule of choice to prepare (99m)Tc radiopharmaceuticals using a fac-{(99m)Tc(CO)3}(+) core.     

A modified sorbent for99mTc generator

A modified sorbent for^99mTe generators of higher activities has been developed. The sorbent consists of two layers. The layer in which (F.P.)⁹⁹Mo is adsorbed contains alumina and silica gel mixture in the weight ratio 40∶60%. The underlaying layer contains 0.5% g of pure alumina. The performances of the columns filled with this sorbent are compared to these containing pure alumina with respect to the total elution efficiency of^99mTc and the elution efficiency ratio of subsequent elutions. Radiochemical and radionuclidic purities (⁹⁹Mo breakthrough) of eluates from both kinds of columns have also been determined and compared.